"可控制的离子干扰"的策略,以促进瘤的MRI导向铁灭疗法
Zhen Chang1, Zhiyu Liang2, Yuming Lan1
1Oral Emergency Department, Hospital of Stomatology, Zhongshan City, Zhangshan528400, China.
ACS applied materials & interfaces
|February 13, 2025
概括
这项研究引入了一种用于治疗口腔状细胞癌 (OSCC) 的新型纳米平台. 它有效地克服了耐药性,并使用金属离子干扰疗法 (MIIT) 实现实时瘤监测.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 口腔状细胞癌 (OSCC) 治疗面临诸如多药物耐药性和不良反应等挑战.
- 金属离子干扰疗法 (MIIT) 提供了一种新的方法来破坏瘤细胞的金属离子平衡并克服抗性.
- 单金属离子输送策略在治疗有效性方面存在局限性.
研究的目的:
- 为OSCC治疗开发一个先进的治疗纳米平台.
- 通过结合多个金属离子和克服耐药性来增强治疗效果.
- 为了实时监测纳米平台在瘤中的输送和积累.
主要方法:
- 制造空洞的半孔二氧化纳米颗粒 (HMON).
- 使用酸加载和控制释放Zn2+和Pt2+离子.
- 在酸性微环境中研究释放的离子对瘤细胞的协同作用.
- 使用Mn2+进行T1磁共振成像 (MRI) 追踪.
主要成果:
- Zn@CDDP@HMON纳米平台有效地破坏OSCC细胞中的细胞内金属离子稳态.
- 释放的 Zn2+ 抑制了线粒体呼吸,而 Pt2+ 激活了 NADPH 氧化酶,增加了活性氧物种 (ROS) 的产生.
- 离子促进芬顿类反应,产生基基和诱导脂质过氧化.
- 减少GSH会使细胞对铁亡产生敏感,而Mn2+则促进T1-MRI用于瘤成像.
结论:
- 开发的纳米平台显示出克服OSCC多药耐药性的巨大潜力.
- 金属离子和ROS生成的组合提供了一个多方面的治疗策略.
- 集成的MRI功能允许精确监测治疗的交付和疗效.
更多相关视频
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
3.0K
04:01Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
844
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...